Formoflo 125 mcg Transhaler is a combination dry powder inhaler containing FDA-approved Formoterol (6 mcg) and Fluticasone Propionate (125 mcg) as its active ingredients. It is prescribed for the long-term maintenance treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD) in adults and adolescents. Lupin Ltd manufactures Formoflo 125 mcg Transhaler in GMP-compliant facilities under strict quality standards.
Formoterol is a Long-acting Beta-2 Adrenergic Agonist (LABA), which works by relaxing the airway muscles, helping to keep the airways open and making breathing easier. It has a rapid onset of action within 1 to 3 minutes and provides long-lasting bronchodilation for up to 12 hours, making it suitable for twice-daily use. This helps prevent symptoms such as wheezing, breathlessness, and airway narrowing.
Fluticasone Propionate is an inhaled corticosteroid (ICS), which works by reducing inflammation in the airways. It suppresses the release of inflammatory substances, helping reduce swelling, mucus production, and airway sensitivity over time. This addresses the underlying cause of persistent symptoms and reduces the risk of flare-ups.
The Transhaler is a breath-actuated dry powder inhaler, meaning the medication is released automatically during inhalation without the need for manual coordination. Some of the common side effects of Formoflo Transhaler include throat irritation, hoarseness, oral thrush, headache, palpitations, and tremors.
Before starting treatment, inform a doctor about any history of cardiovascular disease, Hypertension, Diabetes, Thyroid disorders, or known allergies to the ingredients, as these may affect suitability and monitoring. Store the Transhaler in a dry place below 30°C, away from moisture and sunlight, and keep the cap closed when not in use.
Formoflo 125 Transhaler provides clinically significant benefits for patients requiring consistent long-term control of obstructive airway conditions. Some of them include:
Formoflo 125 mcg Transhaler is a prescription medication that must be used as directed by a healthcare professional. Here are the general guidelines:
Formoflo Transhaler is currently available in a single strength option at Cheap Medicine Shop. However, you can consider the following alternatives:
| Fluticort F 6 mcg/ 250 mcg Inhaler | $28.16/inhaler |
| Combihale FF CFC Free 250 Inhaler | $36.91/inhaler |
| Maxiflo 6 mcg/ 250 mcg Inhaler | $31.72/inhaler |
Like any medication, Formoflo 125 mcg Transhaler can cause some side effects. However, they are generally mild and subside as the body adjusts to treatment. Some of them include:
If these effects worsen with time or persist, seek medical guidance immediately.
Liver Disease
Formoflo Transhaler should be used with caution in patients with liver disease. Impaired liver function may reduce the clearance of Fluticasone Propionate, leading to increased systemic corticosteroid exposure and a higher risk of side effects. Although the risk is minimal in inhaled medicines, always inform a doctor of any liver conditions before initiating treatment.
Kidney Impairment
The Transhaler should be used with caution in patients with kidney disease. While inhaled delivery limits systemic absorption, the cardiovascular effects of Formoterol and the potential for Hypokalemia (low potassium levels) with beta-2 agonist use require evaluation. Inform a doctor of any kidney conditions before starting this medication.
Pregnant and Breastfeeding women
Formoflo 125 mcg Transhaler should not be used during pregnancy as it can harm the baby. Both Formoterol and Fluticasone Propionate can pass into breast milk. So, breastfeeding should be stopped during treatment, unless a doctor confirms safety.
Avoid
Do not use Formoflo 125 mcg Transhaler as a rescue medication for acute Bronchospasm. Avoid in patients with known hypersensitivity to Formoterol, Fluticasone Propionate, or any component of the inhaler. Do not use concurrently with other long-acting beta agonists. Inform a doctor of all current medications, particularly beta-blockers, which can oppose the bronchodilatory effect of Formoterol, and diuretics or other medications affecting potassium levels.
Formoflo Transhaler is a maintenance inhaler used daily to prevent symptoms, not to relieve them once they occur. A rescue inhaler such as Salbutamol acts rapidly to open airways during an acute attack. Both serve distinct roles, and a rescue inhaler should always be available for sudden breathing emergencies.
Yes, Formoflo 125 mcg Transhaler is indicated for the maintenance treatment of COPD in adults. The combination of Formoterol for sustained bronchodilation and Fluticasone Propionate for airway inflammation control helps reduce exacerbation frequency, improve airflow, and support better day-to-day breathing in patients with this condition.
Yes, rinsing your mouth with water and spitting it out after every use is strongly recommended. Residual Fluticasone Propionate in the mouth and throat can promote the growth of Candida, causing oral thrush. This simple step significantly reduces that risk and should not be skipped after any inhalation.
Yes, throat irritation and hoarseness are among the more commonly reported side effects, caused by residual medication in the throat. Rinsing the mouth after each use helps reduce this. If throat irritation is persistent or worsens, consult a doctor, as the inhalation technique or device may need to be reviewed.
If a dose of Formoflo 125 mcg is missed, take it as soon as remembered on the same day. If it is nearly time for the next scheduled dose, leave the missed one and resume with the twice-daily schedule. Do not take two doses at once.
No, Formoflo Transhaler is generally indicated for adults and adolescents aged 12 and above. Its suitability for younger children depends on age, body size, and the ability to use a dry powder inhaler effectively. A doctor will assess whether this formulation and strength are appropriate for the child.
Formoterol begins to act within 1 to 3 minutes of inhalation, providing early bronchodilation. The full anti-inflammatory benefit of Fluticasone Propionate builds gradually over days to weeks of regular use. Consistent daily use is essential, and patients should not discontinue the inhaler even if immediate relief is not apparent.